Back to Journals » OncoTargets and Therapy » Volume 7

Sam68 is a novel marker for aggressive neuroblastoma [Corrigendum]

Authors Zhao X, Li Z, He B, Liu J, Li S, Zhou L, Pan C, Yu Z, Xu Z

Received 5 December 2013

Accepted for publication 5 December 2013

Published 14 August 2014 Volume 2014:7 Pages 1439—1440

DOI https://doi.org/10.2147/OTT.S58769


Zhao X, Li Z, He B, et al. Onco Targets Ther. 2013;6:1751–1760.

In the author affiliation section on the first page, the affiliations were shown incorrectly.

Read the original article

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]